U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
China leaves Merck in need of a new profit injection
Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer ...
Germany's Merck in advanced talks to acquire US biotech firm SpringWorks
Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...
Merck stock price target lowered to $95 by Bernstein SocGen
Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...
FiercePharma3d
UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Is Merck & Co., Inc. (MRK) the Best Dividend Stock According to Wall Street Analysts?
We recently compiled a list of the 10 Best Dow Jones Dividend Stocks According to Wall Street Analysts. In this article, we ...